IP / IT

Juuri Partners

On January 19, 2023, the Finnish private equity firm Juuri Partners Oy has announced its investment in DAF Group Oy, which is responsible for managing Subway’s business in Finland and Sweden through a long-term development agreement. Through the investment, DAF Group will expand its operations in Finland and Sweden, intending to strengthen its restaurant network and invest in its current restaurants’ digitalization and improved guest experience.
Homburger acted as Swiss counsel for Juuri Partners Oy. The Homburger team comprised Luca Dal Molin and Joel Fink (both IP/IT).

Homburger advised Juuri Partners Oy on its investment in DAF Group Oy to accelerate Subway's growth in Finland and Sweden

Corporate / M&A

Healthcare / Life Sciences

Competition

Employment and Executive Compensation

On December 13, 2022, Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that it has entered into a definitive agreement to acquire AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump, an insulin delivery solution.
The consideration includes a previous strategic investment of CHF 8.0 m, an upfront cash payment of CHF 62.4 m, and additional contingent earnout payments of up to CHF 129.6 m, in aggregate, payable upon the achievement of certain milestones. The transaction is subject to the satisfaction of customary closing conditions and is expected to close in January 2023.
Homburger, who also advised AMF Medical on its previous financing rounds, acts as transaction counsel to AMF Medical SA and its shareholders. The Homburger team comprises Andreas Müller, Margrit Marti and Léonard Aeschlimann Perales (all Corporate / M&amp;A; Healthcare / Life Sciences), Luca Dal Molin and Joel Fink (both IP / IT; Healthcare / Life Sciences), Stefan Oesterhelt, Kevin Müller and Philippe Weber (all Tax), Richard Stäuber and Allegra Arnold (both Competition; Healthcare / Life Sciences), and Marc Bircher and Sebastian Wyler (both Employment and Executive Compensation).

Homburger advises AMF Medical and its shareholders on the sale of AMF Medical to Tandem Diabetes Care

Data Protection

HIG Capital

On November 3, 2022, H.I.G. Capital, a leading global investment firm with USD 52 bn of equity capital under management, announced that one of its affiliates has completed the acquisition of Celerion Holdings Inc., a leading full-service provider of outsourced clinical research services to the pharmaceutical industry.
The Homburger team comprised partner Andreas Müller, lead associate Sarah Chevalley, associate Oliver Kneubühl and junior associate Michele Fazari (all Corporate / M&amp;A), associates Joel Fink (IP / IT) and Kirsten Wesiak-Schmidt (Data Protection).

Joel
Fink

Homburger advised Juuri Partners Oy on its investment in DAF Group Oy to accelerate Subway's growth in Finland and Sweden

Homburger advises AMF Medical and its shareholders on the sale of AMF Medical to Tandem Diabetes Care

Homburger advised H.I.G. Capital on its acquisition of Celerion

Auftragsrecht ohne Grenzen?

Erfolgsbedingtheit als Typenmerkmal des Mäklervertrages? Gleichzeitig ein Beitrag zur Frage der Zulässigkeit von Provisionsgarantien

Die neuen Verjährungsfristen und die auftragsrechtliche Aktenaufbewahrung

Join the Team

Joel Fink

Career

Languages

Bar Registration

Teams

JoelFink

Homburger advised Juuri Partners Oy on its investment in DAF Group Oy to accelerate Subway's growth in Finland and Sweden

Homburger advises AMF Medical and its shareholders on the sale of AMF Medical to Tandem Diabetes Care

Homburger advised H.I.G. Capital on its acquisition of Celerion

Auftragsrecht ohne Grenzen?

Erfolgsbedingtheit als Typenmerkmal des Mäklervertrages? Gleichzeitig ein Beitrag zur Frage der Zulässigkeit von Provisionsgarantien

Die neuen Verjährungsfristen und die auftragsrechtliche Aktenaufbewahrung

Join the Team

Joel Fink

Career

Languages

Bar Registration

Teams

Joel
Fink